Targeted delivery of an anti-cancer agent via steroid coupled liposomes

References

• Autenrieth, D., Kan, D., Van Lier, J.E. (1981). Synthesis of 3- and. 6-substituted steroidal heterocycles as potential anticancer agents. Eur J Med Chem. 16:525–8.
   Web of Science ®Google Scholar
• Bangham, A.D., Stansfield, M.M., Walkins, J.C. (1965). Diffusion of univalent ions across the lamellar of swollen phospholipids. J Mol Biol. 13:238–52.
   PubMed Web of Science ®Google Scholar
• Betsch, B. (1990). The pharmacokinetic model and distribution pattern of new sexual-steroid-hormone-linked anticancer agents. J Cancer Res Clin Oncol. 116:467–9.
   PubMed Web of Science ®Google Scholar
• Brix, H.P., Berger, M.R., Schneider, M.R., Tang, W.C., Eisenbrand, G. (1990). Androgen linked alkylating agents: biological activity in methylnitrosourea- induced rat mammary carcinoma. J Cancer Res Clin Oncol. 116:538–49.
   PubMed Web of Science ®Google Scholar
• Das, T., Banerjee, S., Samuel, G., Bapat, K., Subramanian, S., Pillai, M.R.A., Venkatesh, M. (2006). A novel 99mTc-labeled testosterone derivative as a potential agent for targeting androgen receptors. Bioorg Med Chem Lett. 16:5788–92.
   PubMed Web of Science ®Google Scholar
• Denis, L.J., Grifiths, K. (2000). Endocrine treatment in prostate cancer. Sem Surg Oncol. 18:52–74.
   PubMed Web of Science ®Google Scholar
• Diasio, R.B., Harris, B.E. (1989). Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 16:215–37.
   PubMed Web of Science ®Google Scholar
• Fry, D.W., White, J.C., Goldman, I.D. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem. 90:809–15.
   PubMed Web of Science ®Google Scholar
• Gabizon, A., Amselem, S., Goren, D., Cohen, R., Druckmann, S., Fromer, I., Chisin, R., Peretz, T., Sulkes, A., Barenholz, Y. (1990). Preclinical and clinical experience with a doxorubicin-liposome preparation. J Liposome Res. 1:491–502.
   Google Scholar
• Gupta, Y., Jain, A., Jain, P., Jain, S.K. (2007). Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells. J Drug Target. 15:231–40.
   PubMed Web of Science ®Google Scholar
• Gupta, Y., Soni, V., Chourasia, M.K., Jain, A., Khare, P., Jain, S.K. (2005). Targeted drug delivery to the brain via transferrin coupled liposomes. Drug Deliv Tech. 5:66–71.
   Google Scholar
• Hager, G.L., Smith, C.L., Fragoso, G., Wolford, R., Walker, D., Barsony, J., Htun, H. (1998). Intranuclear traffcking and gene targeting by members of the steroid/nuclear receptor superfamily. J Steroid Biochem Molec Biol. 65:25–132.
   Google Scholar
• Hahn, R.G., Moertel, C.G., Schutt, A.J., Bruckner, H.W. (1975). A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer. 35:1031–5.
   PubMed Web of Science ®Google Scholar
• Harding, M., Cowan, S., Hole, D., Cassidy, L., Kitchener, H., Davis, J., Leake, R. (1990). Estrogen and progesterone receptors in ovarian cancer. Cancer. 65:486–91.
   PubMed Web of Science ®Google Scholar
• Hoffmann, J., Sommer, A. (2005). Steroid hormone receptors as targets for the therapy of breast and prostate cancer—recent advances, mechanisms of resistance, and new approaches. J Steroid Biochem Mol Biol. 93:191–200.
   PubMed Web of Science ®Google Scholar
• Hwang, D.R., Scott, M.E., Hedaya, E. (1992). Phospholipids conjugates and their preparation. US patent, 5,106,963.
   Google Scholar
• Kampa, M., Papakonstanti, E.A., Hatzoglou, A., Tathopoulos, E.N., Stournaras, C., Castanas, E. (2002). The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 16:1429–31.
   PubMed Web of Science ®Google Scholar
• Karajgi, J., Jain, N.K., Vyas, S.P. (1993). Passive vectoring of a colloidal carrier system for sodium stibogluconate: preparation, characterization and performance evaluation. J Drug Target. 1:197–206.
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen, J.A., Coleman, R.E., Kins, R.A., Krohan, K.A., Larson, S.M., Mendelsohn, J., Osborne, C.K., Piwnica-Worms, D., Reba, R.C., Siegel, B.A. (1995). Tumor receptor imaging: proceedings of the national cancer institute workshop, review of current work, and prospective for further investigations. Clin Cancer Res. 921:921–32.
   Google Scholar
• Khandare, J., Kolhe, P., Pillai, O., Kannan, S., Lieh-Lai, M., Kannan, R.M. (2005). Synthesis, cellular transport, and activity of polyamidoamine dendrimer methylprednisolone conjugates. Bioconjug Chem. 16:330–7.
   PubMed Web of Science ®Google Scholar
• Kidwai, N., Gong, Y., Sun, X., Deshpande, C.G., Yeldandi, A.V., Rao, M.S., Badve, S. (2004). Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res. 6:18–23.
   PubMed Web of Science ®Google Scholar
• Krishnaiah, Y.S.R., Satyanarayana, V., Kumar, D.B., Karthikeyan, R.S., Bhaskar, P. (2003). In vivo pharmacokinetics in human volunteers: oral administered guar gumbased colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci. 19:355–62.
   PubMed Web of Science ®Google Scholar
• Kuduk, S.D., Harris, C.R., Zheng, F.F., Sepp-Lorenzino, L., Ouerfelli, Q., Rosen, N., Danishefsky, S.J. (2000). Synthesis and evaluation of geldanamycin-testosterone hybrids. Bioorg Med Chem Lett. 10:1303–6.
   PubMed Web of Science ®Google Scholar
• Labianca, R.F., Beretta, G.D., Pessi, M.A. (2001). Disease management consideration. Drugs. 61:1751–64.
   PubMed Web of Science ®Google Scholar
• Langenbach, R.J., Dancenberg, P.V., Heidelberger, C. (1972). Thymidylate synthetase: mechanism of inhibition of 5-fluorouracil-2-deoxyuridylate. Biochem Biophys Res Commun. 48:1565–71.
   PubMed Web of Science ®Google Scholar
• Leuschner, C., Hansel, W. (2005). Targeting breast and prostate cancers through their hormone receptors. Biol Reprod. 73:860–5.
   PubMed Web of Science ®Google Scholar
• Loven, D., Rakowsky, E., Geier, A., Lunenfeld, B., Rubinstein, A., Klein, B., Lurie, H. (1990). A clinical evaluation of nuclear estrogen receptors combined with cytosolic estrogen and progesterone receptors in breast cancer. Cancer. 66:341–6.
   PubMed Web of Science ®Google Scholar
• Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Contr Rel. 65:271–84.
   PubMed Web of Science ®Google Scholar
• Manosroi, A., Kongkaneramit, L.L., Manosroi, J. (2004). Characterization of amphotericin B liposome formulation. Drug Dev Ind Pharm. 30:535–43.
   PubMed Web of Science ®Google Scholar
• Molnar, I., Kute, T., Willingham, M.C., Schwartz, G.G. (2004). 19-Nor-1alpha, 25- dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations. J Steroid Biochem Mol Biol. 89–90:39–43.
   Google Scholar
• Parker, W.B., Cheng, Y.C. (1990). Metabolism and mechanism of action of 5- fluorouracil. Pharmacol Ther. 48:381–95.
   PubMed Web of Science ®Google Scholar
• Rai, S., Paliwal, R., Vaidya, B., Khatri, K., Gupta, P.N., Goyal, A.K., Vyas, S.P. (2008). Targeted delivery of doxorubicin via estrone appended liposomes. J Drug Target. 16:455–63.
   PubMed Web of Science ®Google Scholar
• Rajkowski, K.M., Cittanova, N., Desfosses, B., Jayle, M.F. (1997). The conjugation of testosterone with horseradish peroxidase and a sensitive enzyme assay for the conjugate. Steroids. 29:701–13.
   Google Scholar
• Recht, L., Torres, C.O., Smith, T.W., Raso, V., Griffin, T.W. (1990). Transferrin receptor in normal and neoplastic brain tissue: Implications for brain-tumor immunotherapy. J Neurosurg. 72:941–5.
   PubMed Web of Science ®Google Scholar
• Reddy, B.S., Banerjee, R.K. (2005). 17ß-Estradiol-associated stealth-liposomal delivery of anticancer gene to breast cancer cells. Angew Chem Int Ed. 44:6723–7.
   PubMed Web of Science ®Google Scholar
• Roth, T., Tang, W., Eisenbrand, G. (1995). Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth inhibitory activity in human breast cancer cells. Anticancer Drug Des. 10:655–6.
   PubMedGoogle Scholar
• Rusch, V., Mendelsohn, J., Dmitrovsky, E. (1996). The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev. 7:133–41.
   PubMedGoogle Scholar
• Schuber, F. (1995). Chemistry of ligand coupling to liposomes. In: Philippot, J.R., Schuber, F. (Eds.), Liposomes as tools in basic research and industry. Boca Raton, FL: CRC Press. P. 21.
   Google Scholar
• Seymour, L.W. (1994). Soluble polymer for lectin-mediated targeting. Adv Drug Del Rev. 14:89–111.
   Web of Science ®Google Scholar
• Swamy, N., James, D.A., Mohr, S.C., Hanson, R.N., Ray, R. (2002). An estradiolporphyrin conjugate selectively localizes into estrogen receptor positive breast cancer cells. Bioorg Med Chem. 10:3237–43.
   PubMed Web of Science ®Google Scholar
• Torp, S.H., Helseth, E., Dalen, A., Unsgaard, G. (1991). Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother. 33:61–4.
   PubMed Web of Science ®Google Scholar
• Van, C.E., Peeters, M., Verslype, C., Filez, L., Haustermans, K., Janssens, J. (1999). The medical treatment of colorectal cancer: actual status and new developments. Hepatogastroenterology. 46:709–16.
   PubMed Web of Science ®Google Scholar
• Weitman, S.D., Lark, R.H., Coney, L.R., Fort, D.W., Frasca, V., Zurawski, V.R., Kamen, B.A. (1992). Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:3396–401.
   PubMed Web of Science ®Google Scholar